Avanos Medical, Inc. AVNS
At closeJul 24, 2026, 4:03 PM EDT
After hours · Jul 24, 4:03 PM ET
52-week range unavailable
- YTD
- +122.53%
- 1 year
- +105.34%
- Market cap
- 1.17B
- Profit margin
- -9.69%
- YTD return
- +122.53%
- 1-year return
- +105.34%
- Volume
- 432.16K
- Open
- 24.98
- Previous close
- 24.99
- Day's range
- 24.98 – 25.00
- Earnings date
- Aug 10, 2026
2Y +4.04 (+19.28%)
Key statistics
- Enterprise value
- 1.24B
- PEG ratio
- -0.39
- Price / sales
- 0.00
- Price / book
- 1.48
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Total cash
- 0
- Total debt
- 3
- Return on equity
- -8.91%
- 50-day average
- 0.00
- 200-day average
- 0.00
Analyst view
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Next earnings
Aug 10, 2026
Expected Aug 10, 2026. Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 10, 2026 | Jun 30, 2026 | 0.16 | — | — | — |
| May 5, 2026 | Mar 31, 2026 | 0.16 | 0.22 | +0.06 | +37.50% |
| Feb 24, 2026 | Dec 31, 2025 | 0.24 | 0.29 | +0.05 | +20.83% |
| Nov 5, 2025 | Sep 30, 2025 | 0.12 | 0.22 | +0.10 | +83.33% |
| Aug 5, 2025 | Jun 30, 2025 | 0.18 | 0.17 | -0.01 | -5.56% |
| May 6, 2025 | Mar 31, 2025 | 0.19 | 0.26 | +0.07 | +36.84% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 7, 2024 | JMP Securities | reit | — | Market Perform |
| Jul 25, 2023 | Keybanc | down | Overweight | Sector Weight |
| Jun 21, 2023 | Stifel | reit | Hold | Hold |
| May 22, 2023 | CL King | init | — | Buy |
| May 4, 2023 | Morgan Stanley | main | — | Underweight |
| Feb 22, 2023 | Morgan Stanley | main | — | Underweight |
About Avanos Medical, Inc.
Avanos Medical, Inc. is a pioneering medical technology enterprise dedicated to furnishing device solutions across a broad international footprint, encompassing North America, Europe, the Middle East, Africa, the Asia Pacific region, and Latin America. Its comprehensive product array targets two primary areas: chronic care and non-opioid pain management. Within chronic care, the company provides digestive health offerings such as Mic-Key enteral feeding tubes, Corpak patient feeding systems, and NeoMed solutions tailored for neonatal and pediatric patients. Its respiratory health segment includes closed airway suction systems and other airway management devices, marketed under prominent brands like Ballard, Microcuff, and Endoclear. For non-opioid pain relief, Avanos offers acute pain solutions, including On-Q and ambIT surgical pain pumps, along with Game Ready cold and compression therapy systems. It also features interventional pain solutions, providing minimally invasive therapies like Coolief for long-term pain alleviation. The company facilitates product access by selling directly to hospitals, various healthcare providers, and end-user facilities, in addition to utilizing third-party wholesale distributors. Originally incorporated in 2014 and known as Halyard Health, Inc., the company officially adopted the name Avanos Medical, Inc. in June 2018 and maintains its headquarters in Alpharetta, Georgia.
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- US
- Employees
- 2,287
- Website
- avanos.com
News
V2X To Replace Avanos Medical In The S&P SmallCap 600 Effective Prior To The Opening Of Trading On Monday, July 27 
Top 2 Health Care Stocks That May Plunge This Month 
Top 3 Health Care Stocks That May Collapse This Month 
Deal Dispatch: Amazon Buys Globalstar, Instacart Grabs Instaleap, QVC Announces Bankruptcy 
12 Health Care Stocks Moving In Tuesday's Intraday Session 
Crude Oil Falls Sharply; Wells Fargo Earnings Miss Views 
Avanos Medical, Travere Therapeutics, Globalstar And Other Big Stocks Moving Higher On Tuesday 
12 Health Care Stocks Moving In Tuesday's Pre-Market Session 
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - 12 Health Care Stocks Moving In Tuesday's Intraday Session
Your note
Sign in to keep a note on AVNS — it syncs with the Stock Master app.